Racial Disparities in Cancer Survival Among Randomized Clinical Trials Patients of the Southwest Oncology Group

Journal of the National Cancer Institute - Tập 101 Số 14 - Trang 984-992 - 2009
Kathy S. Albain1, Joseph M. Unger, John J. Crowley, Charles A. Coltman, Dawn L. Hershman
1Department of Medicine, Loyola University Chicago Stritch School of Medicine, Maywood, IL, USA

Tóm tắt

Từ khóa


Tài liệu tham khảo

Edwards, 2005, Annual report to the nation on the status of cancer, 1975–2002, featuring population-based trends in cancer treatment, J Natl Cancer Inst, 97, 1407, 10.1093/jnci/dji289

Jemal, 2004, Annual report to the nation on the status of cancer, 1975–2001, with a special feature regarding survival, Cancer, 101, 3, 10.1002/cncr.20288

Freeman, 1995, Expanding access to cancer screening and clinical follow-up among the medically underserved, Cancer Pract, 3, 19

Underwood, 2003, Reducing the burden of cancer borne by African Americans: if not now, when?, Cancer Epidemiol Biomarkers Prev, 12, 270s

Dignam, 1999, Outcomes among African-Americans and Caucasians in colon cancer adjuvant therapy trials: findings from the National Surgical Adjuvant Breast and Bowel Project, J Natl Cancer Inst, 91, 1933, 10.1093/jnci/91.22.1933

Carey, 2006, Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study, JAMA, 295, 2492, 10.1001/jama.295.21.2492

Bickell, 2006, Missed opportunities: racial disparities in adjuvant breast cancer treatment, J Clin Oncol, 24, 1357, 10.1200/JCO.2005.04.5799

Baldwin, 2005, Explaining black-white differences in receipt of recommended colon cancer treatment, J Natl Cancer Inst, 97, 1211, 10.1093/jnci/dji241

Du, 2007, Meta-analysis of racial disparities in survival in association with socioeconomic status among men and women with colon cancer, Cancer, 109, 2161, 10.1002/cncr.22664

Du, 2006, Racial disparity and socioeconomic status in association with survival in older men with local/regional stage prostate carcinoma: findings from a large community-based cohort, Cancer, 106, 1276, 10.1002/cncr.21732

Hutchins, 1999, Underrepresentation of patients 65 years of age or older in cancer-treatment trials, N Engl J Med, 341, 2061, 10.1056/NEJM199912303412706

Kaplan, 1958, Nonparametric estimation from incomplete observations, J Am Stat Assoc., 53, 451, 10.1080/01621459.1958.10501452

Krieger, 2003, Race/ethnicity, gender, and monitoring socioeconomic gradients in health: a comparison of area-based socioeconomic measures—the public health disparities geocoding project, Am J Public Health, 93, 1655, 10.2105/AJPH.93.10.1655

Grann, 2006, Regional and racial disparities in breast cancer-specific mortality, Soc Sci Med, 62, 337, 10.1016/j.socscimed.2005.06.038

Jatoi, 2003, Widening disparity in survival between white and African-American patients with breast carcinoma treated in the U.S. Department of Defense Healthcare system, Cancer, 98, 894, 10.1002/cncr.11604

Woodward, 2006, African-American race is associated with a poorer overall survival rate for breast cancer patients treated with mastectomy and doxorubicin-based chemotherapy, Cancer, 107, 2662, 10.1002/cncr.22281

Newman, 2006, Meta-analysis of survival in African American and white American patients with breast cancer: ethnicity compared with socioeconomic status, J Clin Oncol, 24, 1342, 10.1200/JCO.2005.03.3472

Dignam, 2000, Differences in breast cancer prognosis among African-American and Caucasian women, CA Cancer J Clin, 50, 50, 10.3322/canjclin.50.1.50

Roach, 1997, Race and survival from breast cancer: based on Cancer and Leukemia Group B trial 8541, Cancer J Sci Am., 3, 107

Bauer, 2007, Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California Cancer Registry, Cancer, 109, 1721, 10.1002/cncr.22618

Morris, 2007, Differences in breast carcinoma characteristics in newly diagnosed African-American and Caucasian patients: a single-institution compilation compared with the National Cancer Institute's Surveillance, Epidemiology, and End Results database, Cancer, 110, 876, 10.1002/cncr.22836

Stewart, 2004, Cancer mortality surveillance—United States, 1990–2000, MMWR Surveill Summ, 53, 1

Powell, 2002, Disease-free survival difference between African Americans and whites after radical prostatectomy for local prostate cancer: a multivariable analysis, Urology, 59, 907, 10.1016/S0090-4295(02)01609-6

Cohen, 2006, Racial differences in clinical progression among Medicare recipients after treatment for localized prostate cancer (United States), Cancer Causes Control, 17, 803, 10.1007/s10552-006-0017-7

Thatai, 2004, Racial disparity in clinical course and outcome of metastatic androgen-independent prostate cancer, Urology, 64, 738, 10.1016/j.urology.2004.05.024

Barnholtz-Sloan, 2002, Ethnic differences in survival among women with ovarian carcinoma, Cancer, 94, 1886, 10.1002/cncr.10415

McGuire, 2002, Race, epithelial ovarian cancer survival, and membership in a large health maintenance organization, Epidemiology, 13, 231, 10.1097/00001648-200203000-00021

Polite, 2005, Colorectal cancer and race: understanding the differences in outcomes between African Americans and whites, Med Clin North Am., 89, 771, 10.1016/j.mcna.2005.03.001

Sundararajan, 2001, Variations in the use of adjuvant chemotherapy for node-positive colon cancer in the elderly: a population-based study, Cancer J, 7, 213

Jessup, 2005, Adjuvant chemotherapy for stage III colon cancer: implications of race/ethnicity, age, and differentiation, JAMA, 294, 2703, 10.1001/jama.294.21.2703

Antman, 1985, Selection bias in clinical trials, J Clin Oncol, 3, 1142, 10.1200/JCO.1985.3.8.1142

Unger, 2006, Outcome of African American women with breast cancer in cooperative group clinical trials, Breast Cancer in Women of African American Descent, 267, 10.1007/978-1-4020-3664-4_11

Partridge, 2003, Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer, J Clin Oncol, 21, 602, 10.1200/JCO.2003.07.071

Hershman, 2009, Treatment quality and outcomes of African American vs White breast cancer patients: retrospective analysis of Southwest Oncology Group studies S8814/S8897, J Clin Oncol, 27, 2157, 10.1200/JCO.2008.19.1163

Guillemette, 2001, Association of genetic polymorphisms in UGT1A1 with breast cancer and plasma hormone levels, Cancer Epidemiol Biomarkers Prev, 10, 711

Guillemette, 2000, Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 and association with breast cancer among African Americans, Cancer Res., 60, 950

Nowell, 2005, Association of genetic variation in tamoxifen-metabolizing enzymes with overall survival and recurrence of disease in breast cancer patients, Breast Cancer Res Treat, 91, 249, 10.1007/s10549-004-7751-x

Bradford, 2002, CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants, Pharmacogenomics, 3, 229, 10.1517/14622416.3.2.229

Fu, 2005, Lung cancer in women: analysis of the national Surveillance, Epidemiology, and End Results database, Chest, 127, 768, 10.1378/chest.127.3.768

Albain, 2007, Toxicity and survival by sex in patients with advanced non-small cell lung carcinoma on modern Southwest Oncology Group (SWOG) trials, J Clin Oncol, 25, 7549, 10.1200/jco.2007.25.18_suppl.7549